TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Ionis Pharmaceuticals at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Ionis Pharmaceuticals takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions focus on oligonucleotide CMC, from regulatory strategy and health authority interactions to manufacturing. It also describes progress toward a greener SPOS process.

OrganizationTIDES Europe 2026 Attendance
Biotech
Develops and markets antisense oligonucleotide medicines for neurological, cardiometabolic and rare diseases.
Talk
Wed Nov 4
08:35–09:05
Regulatory CMC Strategies and Health Authority Interactions for Oligonucleotide Programs
How manufacturing and quality filings for antisense drugs differ between the US and other regions, drawn from recent commercial applications.
Talk
Thu Nov 5
08:35–09:05
Moving Towards a Greener SPOS Process
Practical ways to cut the environmental cost of oligonucleotide synthesis, including smaller wash volumes, new column designs and recycled solvent.

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ionis Pharmaceuticals

Tell us what you sell and we’ll find the people at Ionis Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction